Eden positions itself primarily as a weight loss platform, with peptide therapy as a secondary offering
Your doctor should assess several factors before approving discontinuation, including your current weight status and trajectory, the presence and control of obesity-related comorbidities (type 2 diabetes, hypertension, sleep apnea, cardiovascular disease), your readiness and capacity to implement intensive lifestyle modifications, available support systems and resources, and your history of weight cycling or previous weight loss attempts
Our Sermorelin therapy program is delivered in a supportive, monitored environment
Response varies by individual, and your physician will help optimize timing and dosing for your needs
First, 1740 mL (10 times the quality of medicinal material) of water was added to the medicinal material, soaked for 1 hr, and then heated and refluxed for 1 hr
The field awaits Phase 3 data to determine whether retatrutide's triple agonism translates into clinically meaningful advantages over the already substantial efficacy of tirzepatide